4//SEC Filing
Gangloff Scott A. 4
Accession 0000950170-24-138138
CIK 0001744659other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 8:56 PM ET
Size
7.2 KB
Accession
0000950170-24-138138
Insider Transaction Report
Form 4
Gangloff Scott A.
Chief Technology Officer
Transactions
- Award
Common Stock
2024-12-16+24,300→ 24,300 total - Award
Stock Option (Right to Buy)
2024-12-16+73,700→ 73,700 totalExercise: $29.23Exp: 2034-12-15→ Common Stock (73,700 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in eight (8) equal semi-annual installments, commencing from December 16, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable in forty-eight (48) equal monthly installments, commencing from December 16, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001663253
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 8:56 PM ET
- Size
- 7.2 KB